Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2015. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically in accordance with DTR 3.1.4 R(1)(c).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction notification and contains no financial performance data.
Material Changes
The filing details a change in shareholding for Mrs K Thomson, a connected person of Mr Philip Thomson (a Person Discharging Managerial Responsibility). On April 1, 2015, Mrs K Thomson transferred 1,134 Ordinary Shares held under the Company's ShareReward Plan to a personal shareholding account.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Points
- Verify the identity of the connected person (Mrs K Thomson) and the associated Person Discharging Managerial Responsibility (Mr Philip Thomson).
- Confirm the date of the share transfer (April 1, 2015) and the number of shares involved (1,134 Ordinary Shares).
- Note that this filing does not contain financial results or strategic updates for the company.